Cardiovascular Effects of Splenomegaly and Splenectomy in Beta-Thalassemia Major
Author Information
Author(s): Muacevic Alexander, Adler John R, Abbas Sumira, Khan Haris Ali, Rehman Wajeeha, Shah Mian Mufarih, Mustafa Muhammad, Abbas Muhammad
Primary Institution: Hayatabad Medical Complex, Peshawar, PAK
Hypothesis
What is the cardiovascular impact of splenomegaly compared to splenectomy in patients with beta-thalassemia major?
Conclusion
Splenectomy improves cardiac function and reduces transfusion needs in beta-thalassemia major patients, but it does not eliminate long-term cardiovascular risks.
Supporting Evidence
- Patients with splenectomy had better ejection fractions compared to those with splenomegaly.
- The splenomegaly group showed higher rates of left ventricular hypertrophy and thromboembolic events.
- Splenectomy reduces the risk of cardiomyopathy, especially in younger patients.
- Patients with splenomegaly had worse overall cardiovascular outcomes.
- Splenectomy patients had slightly lower hemoglobin levels but better cardiac function.
- Thromboembolic complications were more common in the splenomegaly group.
- Elevated BNP levels were found in the splenomegaly group, indicating increased cardiac stress.
- Logistic regression indicated splenectomy decreased the risk of cardiomyopathy.
Takeaway
This study shows that removing the spleen helps people with a blood disease feel better, but it can also lead to some heart problems later on.
Methodology
Cross-sectional survey comparing 44 patients with splenomegaly to 44 post-splenectomy patients, assessing various cardiovascular outcomes.
Potential Biases
Potential measurement bias due to different assessment methods across sites.
Limitations
The retrospective design limits causality conclusions, and treatment regimens may vary, affecting comparability.
Participant Demographics
Patients aged 10 to 25 years with beta-thalassemia major, including both genders.
Statistical Information
P-Value
0.028
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website